New York State Common Retirement Fund Kala Pharmaceuticals, Inc. Transaction History

New York State Common Retirement Fund

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$0.3 - $1.31 $7,830 - $34,191	-26,100 Reduced 98.28%	456 $0
Q1 2022 May 05, 2022	BUY	$0.61 - $1.84 $50 - $152	83 Added 0.31%	26,556 $37,000
Q4 2021 Feb 02, 2022	SELL	$1.16 - $2.74 $187 - $443	-162 Reduced 0.61%	26,473 $32,000
Q3 2021 Nov 02, 2021	BUY	$2.62 - $5.43 $537 - $1,113	205 Added 0.78%	26,635 $70,000
Q2 2021 Aug 02, 2021	BUY	$5.06 - $8.15 $1,669 - $2,689	330 Added 1.26%	26,430 $140,000
Q1 2021 May 11, 2021	BUY	$6.24 - $9.58 $19,968 - $30,656	3,200 Added 13.97%	26,100 $176,000
Q4 2020 Feb 08, 2021	SELL	$6.28 - $8.79 $84,152 - $117,785	-13,400 Reduced 36.91%	22,900 $155,000
Q2 2020 Aug 07, 2020	BUY	$8.33 - $13.79 $180,761 - $299,243	21,700 Added 148.63%	36,300 $382,000
Q1 2018 May 10, 2018	BUY	$12.26 - $18.98 $87,046 - $134,758	7,100 Added 94.67%	14,600 $231,000
Q4 2017 Feb 13, 2018	BUY	$13.68 - $23.17 $102,600 - $173,775	7,500	7,500 $139,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $7.83M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.